Interaction of warfarin with drugs, natural substances, and foods

被引:129
作者
Greenblatt, DJ
von Moltke, LL
机构
[1] Tufts Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02111 USA
[2] Tufts Univ, New England Med Ctr, Boston, MA 02111 USA
关键词
warfarin; drug interactions; food interactions; herbal interactions;
D O I
10.1177/0091270004271404
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Variability in the anticoagulant response to warfarin is an ongoing clinical dilemma. Fluctuations in dietary vitamin Kare an important source of variance, and the need for constancy in vitamin K intake is routinely emphasized for warfarintreated patients. Anticoagulant response is also influenced by a number of drugs that induce or inhibit warfarin metabolism, as well as by genetic polymorphisms that may modulate expression or activity of CYP2C9, the isoform mediating clearance of S-warfarin. The possible role of dietary factors other than vitamin K, as well as of herbal medicines or supplements as contributors to the instability of anticoagulation in warfarin-treated patients, has received recent attention. St. John's wort and possibly some ginseng formulations may have the potential to diminish warfarin anticoagulation, apparently by inducing CYP2C9 activity. Otherwise, there is no reliable evidence to indicate that any dietary component (other than vitamin K) or any herbal product has an effect on the anticoagulant response to warfarin. Scientific conclusions on this important therapeutic issue should be based on valid scientific data rather than unvalidated case reports.
引用
收藏
页码:127 / 132
页数:6
相关论文
共 79 条
[1]   Herbal medicines and perioperative care [J].
Ang-Lee, MK ;
Moss, J ;
Yuan, CS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (02) :208-216
[2]   Changes in plasma protein binding have little clinical relevance [J].
Benet, LZ ;
Hoener, BA .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (03) :115-121
[3]  
BEVAN DH, 2004, BRIT MED J, V327, P1454
[4]  
Beyth Rebecca J, 2002, Expert Opin Drug Saf, V1, P129, DOI 10.1517/14740338.1.2.129
[5]  
Beyth Rebecca J, 2002, Curr Hematol Rep, V1, P41
[6]  
Booth SL, 1999, NUTR REV, V57, P288
[7]   Dietary intake and adequacy of vitamin K [J].
Booth, SL ;
Suttie, JW .
JOURNAL OF NUTRITION, 1998, 128 (05) :785-788
[8]   Adverse interactions between warfarin and nonsteroidal antiinflammatory drugs: Mechanisms, clinical significance, and avoidance [J].
Chan, TYK .
ANNALS OF PHARMACOTHERAPY, 1995, 29 (12) :1274-1283
[9]   Induction of human CYP2C9 by rifampicin, hyperforin, and phenobarbital is mediated by the pregnane X receptor [J].
Chen, YP ;
Ferguson, SS ;
Negishi, M ;
Goldstein, JA .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 308 (02) :495-501
[10]   The association of vitamin K status with warfarin sensitivity at the onset of treatment [J].
Cushman, M ;
Booth, SL ;
Possidente, CJ ;
Davidson, KW ;
Sadowski, JA ;
Bovill, EG .
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 112 (03) :572-577